---
document_datetime: 2026-01-20 16:24:00
document_pages: 3
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/spikevax-previously-covid-19-vaccine-moderna-epar-all-authorised-presentations_en.pdf
document_name: spikevax-previously-covid-19-vaccine-moderna-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 2.8387102
conversion_datetime: 2026-01-20 20:28:18.123473
docling_version:
  docling-serve: 1.10.0
  docling-jobkit: 1.8.1
  docling: 2.69.0
  docling-core: 2.60.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.3
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
| MA (EU) number   | (Invented) name   | Strength   | Pharmaceutical Form      | Route of Administration   | Immediate Packaging                                                 | Content (concentration)   | Pack size                            |
|------------------|-------------------|------------|--------------------------|---------------------------|---------------------------------------------------------------------|---------------------------|--------------------------------------|
| EU/1/20/1507/019 | Spikevax JN.1     | -- 6       | Dispersion for injection | Intramuscular use         | vial (glass)                                                        | 2.5 ml (5 or 10 doses)    | 10 multidose vials (50 or 100 doses) |
| EU/1/20/1507/020 | Spikevax JN.1     | -- 6       | Dispersion for injection | Intramuscular use         | vial (cyclic olefin polymer)                                        | 2.5 ml (5 or 10 doses)    | 10 multidose vials (50 or 100 doses) |
| EU/1/20/1507/021 | Spikevax JN.1     | -- 6       | Dispersion for injection | Intramuscular use         | vial (glass)                                                        | 0.5 ml (1 dose)           | 1 single dose vial (1 dose)          |
| EU/1/20/1507/022 | Spikevax JN.1     | -- 6       | Dispersion for injection | Intramuscular use         | vial (glass)                                                        | 0.5 ml (1 dose)           | 10 single dose vials (10 doses)      |
| EU/1/20/1507/023 | Spikevax JN.1     | -- 6       | Dispersion for injection | Intramuscular use         | pre-filled syringe (cyclic olefin copolymer) in                     | 0.5 ml (1 dose)           | 1 pre-filled syringe (1 dose)        |
| EU/1/20/1507/024 | Spikevax JN.1     | -- 6       | Dispersion for injection | Intramuscular use         | a blister pre-filled syringe (cyclic olefin copolymer) in a blister | 0.5 ml (1 dose)           | 10 pre-filled syringes (10 doses)    |
| EU/1/20/1507/025 | Spikevax JN.1     | -- 6       | Dispersion for injection | Intramuscular use         | pre-filled syringe (cyclic olefin copolymer) in a tray              | 0.5 ml (1 dose)           | 1 pre-filled syringe (1 dose)        |
| EU/1/20/1507/026 | Spikevax JN.1     | -- 6       | Dispersion for injection | Intramuscular use         | pre-filled syringe (cyclic olefin copolymer) in a tray              | 0.5 ml (1 dose)           | 10 pre-filled syringes (10 doses)    |

<div style=\"page-break-after: always\"></div>

| MA (EU) number   | (Invented) name   | Strength   | Pharmaceutical Form      | Route of Administration   | Immediate Packaging                                                 | Content (concentration)   | Pack size                            |
|------------------|-------------------|------------|--------------------------|---------------------------|---------------------------------------------------------------------|---------------------------|--------------------------------------|
| EU/1/20/1507/031 | Spikevax LP.8.1   | -- 7       | Dispersion for injection | Intramuscular use         | vial (glass)                                                        | 2.5 ml (5 or 10 doses)    | 10 multidose vials (50 or 100 doses) |
| EU/1/20/1507/032 | Spikevax LP.8.1   | -- 7       | Dispersion for injection | Intramuscular use         | vial (cyclic olefin polymer)                                        | 2.5 ml (5 or 10 doses)    | 10 multidose vials (50 or 100 doses) |
| EU/1/20/1507/033 | Spikevax LP.8.1   | -- 7       | Dispersion for injection | Intramuscular use         | pre-filled syringe (cyclic olefin copolymer) in                     | 0.5 ml (1 dose)           | 1 pre-filled syringe (1 dose)        |
| EU/1/20/1507/034 | Spikevax LP.8.1   | -- 7       | Dispersion for injection | Intramuscular use         | a blister pre-filled syringe (cyclic olefin copolymer) in a blister | 0.5 ml (1 dose)           | 10 pre-filled syringes (10 doses)    |
| EU/1/20/1507/035 | Spikevax LP.8.1   | -- 7       | Dispersion for injection | Intramuscular use         | pre-filled syringe (cyclic olefin copolymer) in                     | 0.5 ml (1 dose)           | 1 pre-filled syringe (1 dose)        |
| EU/1/20/1507/036 | Spikevax LP.8.1   | -- 7       | Dispersion for injection | Intramuscular use         | pre-filled syringe (cyclic olefin copolymer) in                     | 0.5 ml (1 dose)           | 10 pre-filled syringes (10 doses)    |
| EU/1/20/1507/037 | Spikevax LP.8.1   | -- 7       | Dispersion for injection | Intramuscular use         | a tray pre-filled syringe (cyclic olefin copolymer) in a blister    | 0.25 ml (1 dose)          | 1 pre-filled syringe (1 dose)        |

<div style=\"page-break-after: always\"></div>

| MA (EU) number   | (Invented) name   | Strength   | Pharmaceutical Form      | Route of Administration   | Immediate Packaging                                       | Content (concentration)   | Pack size                         |
|------------------|-------------------|------------|--------------------------|---------------------------|-----------------------------------------------------------|---------------------------|-----------------------------------|
| EU/1/20/1507/038 | Spikevax LP.8.1   | -- 7       | Dispersion for injection | Intramuscular use         | pre-filled syringe (cyclic olefin copolymer) in a blister | 0.25 ml (1 dose)          | 10 pre-filled syringes (10 doses) |
| EU/1/20/1507/039 | Spikevax LP.8.1   | -- 7       | Dispersion for injection | Intramuscular use         | pre-filled syringe (cyclic olefin copolymer) in a tray    | 0.25 ml (1 dose)          | 1 pre-filled syringe (1 dose)     |
| EU/1/20/1507/040 | Spikevax LP.8.1   | -- 7       | Dispersion for injection | Intramuscular use         | pre-filled syringe (cyclic olefin copolymer) in a tray    | 0.25 ml (1 dose)          | 10 pre-filled syringes (10 doses) |

-- 6

One dose (0.5 mL) contains 50 micrograms of SARS-CoV-2 JN.1 mRNA, a COVID-19 mRNA Vaccine (embedded in lipid nanoparticles).

One dose (0.25 mL) contains 25 micrograms of SARS-CoV-2 JN.1 mRNA, a COVID-19 mRNA Vaccine (embedded in lipid nanoparticles).

SARS-CoV-2 JN.1 mRNA is a single-stranded, 5'-capped messenger RNA (mRNA) produced using a cell-free in vitro transcription from the corresponding DNA templates, encoding the viral spike (S) protein of SARS-CoV-2 (JN.1).

-- 7

One dose (0.5 mL) contains 50 micrograms of SARS-CoV-2 LP.8.1 mRNA, a COVID-19 mRNA Vaccine (embedded in lipid nanoparticles).

One dose (0.25 mL) contains 25 micrograms of SARS-CoV-2 LP.8.1 mRNA, a COVID-19 mRNA Vaccine (embedded in lipid nanoparticles).

SARS-CoV-2 LP.8.1 mRNA is a single-stranded, 5'-capped messenger RNA (mRNA) produced using a cell-free in vitro transcription from the corresponding DNA templates, encoding the viral spike (S) protein of SARS-CoV-2 (LP.8.1).